Intepirdine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIntepirdine
Drug Alias Name英特匹定IntepirdinaIntepirdinum英特吡啶GSK-742457 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsAlzheimer DiseaseLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[27] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoivant Sciences IncGlaxosmithkline PlcSio Gene Therapies Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseLewy Body Disease

Other Information

ATC CodeN/A
Related LinksWikipedia